L'antidépresseur spray nasal, Spravato, approuvé aux États-Unis
Spravato / Esketamine - Brain Health Consultants and TMS Center - Houston, TX
Spravato Debate Still Rages | MedPage Today
Brian Buggie, MD - SPRAVATO is the new FDA-approved esketamine nasal spray for treatment-resistant depression (TRD) in adults. It will be interesting to learn about its efficacy vs KETAMIND, the off-label nasal